Contact OTC Dynamics on Twitter OTC Dynamics on Facebook
Custom solutions for retail traders

Tag: Marinus Pharmaceuticals Inc. News

$MRNS Marinus Pharmaceuticals Expands Enrollment Criteria to Support Recruitment in Phase 3 RAISE Trial in Refractory Status Epilepticus
on June 8, 2022 News and Tags: , , , with 0 comments
Time:
7:30 AM
Symbol:
MRNS
Source:
Business Wire
Read more

$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
on June 3, 2022 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
MRNS
Source:
Business Wire
Read more

$MRNS Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences
on May 18, 2022 News and Tags: , , , with 0 comments
Time:
9:00 AM
Symbol:
MRNS
Source:
Business Wire
Read more

$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
on April 18, 2022 News and Tags: , , , with 0 comments
Time:
4:30 PM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals Announces Publication in The Lancet Neurology of ZTALMY® (ganaxolone) Phase 3 Marigold Trial Results
on April 14, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals Announces FDA Approval of ZTALMY® (ganaxolone) for CDKL5 Deficiency Disorder
on March 18, 2022 News and Tags: , , , with 0 comments
Time:
2:29 PM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
on March 15, 2022 News and Tags: , , , with 0 comments
Time:
4:30 PM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals Announces Delay to RAISE Phase 3 Clinical Trial in Status Epilepticus and Associated IV Ganaxolone Clinical Trials
on February 22, 2022 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
on February 10, 2022 News and Tags: , , , with 0 comments
Time:
5:00 PM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
on January 14, 2022 News and Tags: , , , with 0 comments
Time:
5:00 PM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright Bioconnect Conference
on January 5, 2022 News and Tags: , , , with 0 comments
Time:
7:30 AM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
on December 27, 2021 News and Tags: , , , with 0 comments
Time:
5:00 PM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals Announces New Clinical and Research Data to be Presented at American Epilepsy Society Meeting
on December 3, 2021 News and Tags: , , , with 0 comments
Time:
10:01 AM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals to Present at Multiple Upcoming Investor Conferences
on November 15, 2021 News and Tags: , , , with 0 comments
Time:
7:30 AM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
on November 8, 2021 News and Tags: , , , with 0 comments
Time:
5:00 PM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals Joins the Loulou Foundation in Collaboration on CANDID, a Comprehensive Observational Study in CDKL5 Deficiency Disorder
on October 25, 2021 News and Tags: , , , with 0 comments
Time:
8:01 AM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
on October 8, 2021 News and Tags: , , , with 0 comments
Time:
4:31 PM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals Announces Virtual R&D Event on October 5, 2021
on September 28, 2021 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
on September 9, 2021 News and Tags: , , , with 0 comments
Time:
4:30 PM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals Reports Topline Ganaxolone Phase 2 Open-Label Results in Tuberous Sclerosis Complex and Receives FDA Orphan Drug Designation
on August 17, 2021 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more